---All---
  • ---All---
  • Accession
  • Catalog #

MKNK2 Antibody (C-term) Blocking PeptideSynthetic peptide

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
BP7152a 0.1 mg 400 ul In Stock $ 45.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

MKNK2 Antibody (C-term) Blocking Peptide - Product info

Primary AccessionQ9HBH9
Clone Names4012628
Calculated MW51875 Da

MKNK2 Antibody (C-term) Blocking Peptide - Additional info

Gene ID 2872
Target/Specificity
The synthetic peptide sequence used to generate the antibody AP7152a was selected from the C-term region of human MKNK2. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Format
The synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml deionized water for a final concentration of 1 mg/ml.
Storage
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.
Precautions
This product is for research use only. Not for use in diagnostic or therapeutic procedures.

MKNK2 Antibody (C-term) Blocking Peptide - Protein Information

Name MKNK2
Synonyms GPRK7, MNK2
Function
Serine/threonine-protein kinase that phosphorylates SFPQ/PSF, HNRNPA1 and EIF4E. May play a role in the response to environmental stress and cytokines. Appears to regulate translation by phosphorylating EIF4E, thus increasing the affinity of this protein for the 7-methylguanosine-containing mRNA cap Required for mediating PP2A-inhibition-induced EIF4E phosphorylation. Triggers EIF4E shuttling from cytoplasm to nucleus. Isoform 1 displays a high basal kinase activity, but isoform 2 exhibits a very low kinase activity. Acts as a mediator of the suppressive effects of IFNgamma on hematopoiesis. Negative regulator for signals that control generation of arsenic trioxide As(2)O(3)-dependent apoptosis and anti-leukemic responses Involved in anti-apoptotic signaling in response to serum withdrawal
Cellular Location
Isoform 2: Nucleus, PML body.
Tissue Location
Ubiquitously expressed in all tissues examined. Isoform 2 is expressed at higher levels in the ovary than is isoform 1

MKNK2 Antibody (C-term) Blocking Peptide - Related products

AP7058a: MNK2 (MKNK2) Antibody (N-term)

AP7152a: MNK2 (MKNK2) Antibody (C-term)

RI13315: MKNK2 predesign siRNA

BP7058a: MKNK2 Antibody (N-term) Blocking Peptide

BP7152a: MKNK2 Antibody (C-term) Blocking Peptide

AT2875a: MKNK2 Antibody (monoclonal) (M04)

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

MKNK2 may play a role in the response to environmental stress and cytokines. This protein appears to regulate transcription by phosphorylating EIF4E, thus increasing the affinity of this protein for the 7-methylguanosine-containing mRNA cap.

REFERENCES

Scheper, G.C., et al., Mol. Cell. Biol. 23(16):5692-5705 (2003).Knauf, U., et al., Mol. Cell. Biol. 21(16):5500-5511 (2001).Scheper, G.C., et al., Mol. Cell. Biol. 21(3):743-754 (2001).Slentz-Kesler, K., et al., Genomics 69(1):63-71 (2000).Haribabu, B., et al., Proc. Natl. Acad. Sci. U.S.A. 90(20):9398-9402 (1993).